Search

Your search keyword '"Heneghan, Michael A."' showing total 1,078 results

Search Constraints

Start Over You searched for: Author "Heneghan, Michael A." Remove constraint Author: "Heneghan, Michael A."
1,078 results on '"Heneghan, Michael A."'

Search Results

1. microRNA associated with hepatocyte injury and systemic inflammation may predict adverse outcomes in cirrhotic patients

2. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

3. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

4. Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis

5. Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery

6. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis

9. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

11. Exploring Notions of Resilience and Adaptability in the Context of Piloting a Mobile App for Risk Awareness During Covid-19

16. Invasive coronary angiography as a tool in cardiac evaluation for liver transplant candidates

17. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

18. The impact of advanced patient age in liver transplantation: a European Liver Transplant Registry propensity-score matching study

21. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

24. WED-137-YI Reviewing the largest experience of liver transplantation for Wilson’s disease in the UK: single centre review of patient and graft outcomes and long term survival

25. THU-111 Second-line treatment in recurrent primary biliary cholangitis after liver transplantation: an international multicentre study

26. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial

27. SAT-057 Poor radiological-histopathological concordance in patients transplanted for hepatocellular carcinoma: a single centre experience

28. SAT-021 Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival in an international multicentre cohort

30. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with Primary Biliary Cholangitis- an ELTR study

31. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

32. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis

34. A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure

37. Exploring Notions of Resilience and Adaptability in the Context of Piloting a Mobile App for Risk Awareness During Covid-19

40. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

43. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

44. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

46. Features and outcome of AIH patients without elevation of IgG

47. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

Catalog

Books, media, physical & digital resources